Circulating Tumor Cell Counts in Patients With Localized Prostate Cancer Including Those Under Active Surveillance

Conclusion: CTC counts in localized prostate cancer were associated with Gleason pattern 5. Active treatment should be considered for patients with low-risk disease during active surveillance who are found to have EpCAM+ CTCs because of a risk of up-staging and up-grading.

Source: In Vivo - August 29, 2019 Category: Research Authors: CHOI, S. Y., LIM, B., KYUNG, Y. S., KIM, Y., KIM, B. M., JEON, B. H., PARK, J. C., SOHN, Y. W., LEE, J. H., UH, J.-H., JANG, S., KIM, C.-S. Tags: Clinical Studies Source Type: research